About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

OnTrackCF: Engagement, Feasibility, and Acceptability Study

NCT07031323·3 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Emma M McWilliams, BA
CONTACT
617-355-7534 emma.mcwilliams@childrens.harvard.edu
Callie Bacon, MPH
CONTACT
617-919-7696 callie.bacon@childrens.harvard.edu

Lead

Boston Children's Hospital

With

Cystic Fibrosis Foundation
Johns Hopkins University
University of Alabama at Birmingham

Age

18–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

1. Diagnosed with CF
2. 18+ years of age
3. Prescribed a CFTR modulator therapy to be taken twice a day
4. Can speak and read English
5. Have regular access to an iOS or Android tablet or smartphone with internet access.

You may not be if

1\) Any situation, in the opinion of the Investigator, that would compromise the safety of the patient or the quality of the data

The record

StatusRecruiting

PhaseNo phase

Taking part60

StartedNov 2025

UpdatedDec 5, 2025

Conditions

Cystic Fibrosis (CF)Cystic Fibrosis - Complete

Where3

University of Alabama-Birmingham
Birmingham, Alabama, United States
Johns Hopkins University
Baltimore, Maryland, United States
Boston Children's Hospital
Boston, Massachusetts, United States

Clareo Health | OnTrackCF: Engagement, Feasibility, and Acceptability Study